COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

Pooled Testing: What Your Lab Needs to Know About Managing a Fall/Winter Surge in the COVID-19 Pandemic

Pooled Testing: What Your Lab Needs to Know About Managing a Fall/Winter Surge in the COVID-19 Pandemic
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
Share on email
Email
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on whatsapp
Share on email

Dark Daily and COVID-19 STAT Intelligence Briefings is offering this FREE webinar as a service to our clinical lab and pathology colleagues

FREE Webinar
Wednesday, December 2 at 1 PM EST

Register Now

The arrival of fall each year brings with it flu season. This year, the U.S. influenza season is particularly worrisome as we continue to battle the COVID-19 (SARS-CoV-2) pandemic. With the peak of flu season spanning several months and possibly into the spring of 2021, clinical laboratories will likely see dramatic upward swings in the number of people who need flu and SARS-CoV-2 testing simultaneously, while at the same time being faced with an acute shortage of tests and testing supplies.

What steps can be taken on a systemic level within the laboratory industry to help manage the potential onslaught of infection and likelihood of increased testing? One promising answer is pooled testing. Pooled testing is one way to use the clinical laboratory’s testing supplies, resources, and efforts wisely, and is receiving significant attention as a method of performing large volumes of clinical laboratory tests while conserving critical testing resources. This testing method was also recognized by the US Food and Drug Administration (FDA) over the summer.

Attend this complimentary webinar, with follow-up Q&A, to learn about the pros and cons of pooled testing and how they must be evaluated when determining if pooled testing is the right solution for meeting your lab’s SARS-CoV-2 and seasonal flu testing demands.

Register Now

Attend this 60-minute program, and you will:

  • Understand the concept of pooled testing in the clinical laboratory setting, specifically for COVID-19
  • Weigh the pros and cons of pooled testing for a given population and/or outbreak
  • Learn when pooled testing may be the right solution for your laboratory, and when it may not
  • Uncover potential benefits of the proper use of pooled testing, including decreased TAT, bulk test order processing, increased staff efficiency, and more efficient use of supplies
  • Evaluate the most important features of pooled testing workflow technology, such as vendor-agnostic LIS connectivity, pool protection, test validation rules, and support for compliant reporting
  • Plus real-world examples of pooled testing for COVID-19 including detailed workflow visuals highlighting both orders and results, and much more!

Who should attend?

  • CIOs/CMIOs
  • Lab Directors and Lab Managers
  • Pathologists
  • Molecular lab leaders

Your registration includes:

  • A site license to attend the webinar. Invite as many members of your team as you would like!
  • The opportunity to pose specific questions, and connect directly with the panel, during a Q&A session

With your attendance of this webinar, you will gain a clear understanding of when it makes sense to implement pooled testing, specifically for COVID-19, understand the potential benefits of pooled testing, as well as learn the important features to look for when selecting pooled testing workflow technology.

Register Now

Panel Speakers:

Amanda Caudle
Director, Product Management
Sunquest

Danielle Tangorre, Esq.
General Counsel, NILA
Shareholder, O’Connell & Aronowitz

Kiran Ganda
Director, Product Marketing
Sunquest
(Moderator)

Sponsored by:

 

COVID-19 TESTING DATA

Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at rmichel@darkreport.com.

Sincerely,

Robert L. Michel
President, Founder
The Dark Intelligence Group